The protein manufacturing industry faces many challenges today – large stainless steel bioreactors cause downstream processing bottlenecks and come with a large footprint and high CAPEX. To address these challenges, DSM Biologics has developed the XD® Process Technology. This proprietary technology uses disposable systems to simplify the downstream process and lower CAPEX. In this on-demand webcast, Rolf Douwenga, Vice President of Global Research and Development for DSM Biologics, discusses:
Issues Facing Protein Manufacturing Industry
How DSM Addresses These Issues
In-depth Explanation of XD Process Technology
Join Douwenga as he details several case studies using XD Process Technology to enable a more flexible and simplified downstream process.
This information is brought to you by DSM.
![unlimited-dsm.jpg unlimited-dsm.jpg](https://eu-images.contentstack.com/v3/assets/blt0a48a1f3edca9eb0/blt59622cc6c2ff98c1/658051604f115d040aa034d9/unlimited-dsm.jpg?width=700&auto=webp&quality=80&disable=upscale)